Selected article for: "miRNA expression and network analysis"
Title: Research Communications of the 24th ECVIM-CA Congress
  • Document date: 2015_1_10
    • ID: r59usk02_51
    Snippet: No conflicts of interest reported. MicroRNAs (miRNA) are short (19-22 nucleotides), singlestranded, non-coding RNAs that specifically anneal with complementary sequences in multiple mRNA targets, and they silence mRNAs and suppress downstream protein translation. A miRNA can act as a fine-tuner of gene expression or an on/off switch. These features highlight the potential of miR-NAs as therapeutic targets. The role of miRNAs in myocardial fibrosi.....
    Document: No conflicts of interest reported. MicroRNAs (miRNA) are short (19-22 nucleotides), singlestranded, non-coding RNAs that specifically anneal with complementary sequences in multiple mRNA targets, and they silence mRNAs and suppress downstream protein translation. A miRNA can act as a fine-tuner of gene expression or an on/off switch. These features highlight the potential of miR-NAs as therapeutic targets. The role of miRNAs in myocardial fibrosis and hypertrophic cardiomyopathy has been widely studied in human patients. However, there is no data available for canine and human myxomatous mitral valve disease (MMVD). The aim of this study was to investigate miRNA transcriptomics in canine MMVD by using global transcriptional profiling, miRNA target prediction software (DIANA Tool, TargetScan 6.2) and network analysis software (BioLayout Express 3D ).

    Search related documents:
    Co phrase search for related documents
    • analysis software and human patient: 1
    • analysis software and interest conflict: 1, 2
    • analysis software and network analysis software: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • analysis software and non coding rna: 1
    • analysis software and protein translation: 1
    • analysis software and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • analysis software and target prediction: 1
    • analysis software and therapeutic target: 1, 2, 3, 4, 5
    • complementary sequence and gene expression: 1, 2, 3, 4, 5, 6, 7
    • complementary sequence and mRNA target: 1, 2, 3
    • complementary sequence and target prediction: 1
    • downstream protein translation and gene expression: 1
    • downstream protein translation and protein translation: 1, 2, 3, 4, 5